Skip to main content
. 2020 Nov 13;39(1):81–87. doi: 10.5114/ada.2020.100824

Figure 1.

Figure 1

Serum interleukin-31 (IL-31) level in patients with cutaneous T-cell lymphoma (CTCL), atopic dermatitis (AD) and healthy control group (p < 0.001). Asterisks indicate differences between CTCL, AD and healthy control group